IP Watchdog

Our 6th annual IPWatchdog LIVE conference will be held on March 22-24, of 2026 at the Renaissance Arlington Capital View hotel in Arlington, VA.

Bites (noun): more meaty news to sink your teeth into. Barks (noun): peripheral noise worth your attention. Want to have your doggie(s) featured in one of our future Barks & Bites Columns? Send your dogs photo(s) along with their name, breed (if you know it) and their age to dogwall@ipwatchdog.com. All photos will be added to the IPWatchdog Dog Wall at IPWatchdog Studios and will be added to the queue of images we select from each week.

“The CAFC concluded that ‘the basis was not meaningfully presented to the district court, and it was therefore forfeited.’” The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision today in Truinject Corp. v. Galderma S.A., affirming a U.S. District Court for the District of Delaware judgment for Galderma S.A. on tortious interference, breach of contract, and trade secret misappropriation claims.

Erik Iverson is is Associate General Counsel with the Bill & Melinda Gates Foundation, working exclusively with Foundation’s Global Health initiate. He will be the keynote speaker at the BIO IP Counsels Committee Conference, which will be held in Seattle, Washington from April 13-15, 2011. As a prelude to his presentation at BIO Mr. Iverson agreed to go on the record with me.

Frankly I am getting rather sick and tired of those who oppose intellectual property protections ignoring the overwhelming truth that patents and other forms of intellectual property are a net positive for society. These anti-patent and anti-intellectual property zealots purport to present objective facts, but if you look at their reports there is never anything other than conjecture and speculation.

“We conclude the claims are not indefinite because, although they encompass inoperable embodiments, the claims are clear about what they cover.” – CAFC The U.S. Court of Appeals for the Federal Circuit (CAFC) on Thursday issued a precedential decision affirming a finding of invalidity of certain claims of Satius Holding, LLC’s wireless communications patent, but holding that the district court’s reasoning, which focused on indefiniteness, was erroneous.

“[D]evice-level SEP licensing… maximizes the accuracy of assessing royalties by using the measure of economic value closest to the point of sale.” On October 7, a coalition of 25 experts in intellectual property and competition law who serve or have served as U.S. judges, U.S. government officials, legal scholars and economists submitted a comment to the United Kingdom Intellectual Property Office (UKIPO) as part of that agency’s Open Consultation on Standard Essential Patents (SEPs) in order...

Whenever a company name is splashed through the headlines regarding some big deal, unsolicited advice is never far behind. Cocktail party chatter and water-cooler insight all include some sage observation. I cannot resist, even if I am a little late to the party. Firstly, well done. Buying Motorola Mobility was an excellent move. No one ever said Google (NASDAQ: GOOG) had to be a pure play on or in anything in particular. If it wants to integrate laterally/vertically, good.

“Patent rights continue to play an important role in protecting innovation, but their value is closely tied to a company’s ability to act on them.” Patent infringement litigation is often discussed in terms of high-profile disputes or headline verdicts. What receives less attention is the cost of getting there. Whether a company is enforcing its patent rights or defending against a claim, the financial impact of patent litigation can be significant long before a case ever reaches trial.

Licensing your invention is a lot easier if you can show that it’s selling. That means you have to produce a small quantity of your product. Nice idea – until you learn that a plastic injection mold costs $25,000. Now what? Fortunately, there are options. You just have to know where to look. Small-quantity manufacturing lies between rapid prototyping processes and volume production. To discover the processes in the low- to mid-quantity range, visit  www.jobshop.com.